HUMANA INC (HUM) Fundamental Analysis & Valuation

NYSE:HUM • US4448591028

Current stock price

165.43 USD
+1.76 (+1.08%)
At close:
166 USD
+0.57 (+0.34%)
After Hours:

This HUM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HUM Profitability Analysis

1.1 Basic Checks

  • HUM had positive earnings in the past year.
  • HUM had a positive operating cash flow in the past year.
  • In the past 5 years HUM has always been profitable.
  • HUM had a positive operating cash flow in each of the past 5 years.
HUM Yearly Net Income VS EBIT VS OCF VS FCFHUM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

1.2 Ratios

  • The Return On Assets of HUM (2.43%) is comparable to the rest of the industry.
  • The Return On Equity of HUM (6.73%) is better than 62.38% of its industry peers.
  • HUM has a better Return On Invested Capital (6.36%) than 64.36% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HUM is in line with the industry average of 8.98%.
Industry RankSector Rank
ROA 2.43%
ROE 6.73%
ROIC 6.36%
ROA(3y)3.44%
ROA(5y)4.69%
ROE(3y)9.8%
ROE(5y)13.19%
ROIC(3y)7.34%
ROIC(5y)7.68%
HUM Yearly ROA, ROE, ROICHUM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With a Profit Margin value of 0.92%, HUM perfoms like the industry average, outperforming 55.45% of the companies in the same industry.
  • In the last couple of years the Profit Margin of HUM has declined.
  • HUM has a Operating Margin of 2.63%. This is comparable to the rest of the industry: HUM outperforms 52.48% of its industry peers.
  • HUM's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.63%
PM (TTM) 0.92%
GM N/A
OM growth 3Y-16.25%
OM growth 5Y-16.48%
PM growth 3Y-32.82%
PM growth 5Y-26.81%
GM growth 3YN/A
GM growth 5YN/A
HUM Yearly Profit, Operating, Gross MarginsHUM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

1

2. HUM Health Analysis

2.1 Basic Checks

  • HUM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, HUM has about the same amount of shares outstanding.
  • The number of shares outstanding for HUM has been reduced compared to 5 years ago.
  • Compared to 1 year ago, HUM has a worse debt to assets ratio.
HUM Yearly Shares OutstandingHUM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
HUM Yearly Total Debt VS Total AssetsHUM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • The Debt to FCF ratio of HUM is 32.98, which is on the high side as it means it would take HUM, 32.98 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 32.98, HUM is not doing good in the industry: 63.37% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.70 indicates that HUM is somewhat dependend on debt financing.
  • The Debt to Equity ratio of HUM (0.70) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 32.98
Altman-Z N/A
ROIC/WACC0.8
WACC7.98%
HUM Yearly LT Debt VS Equity VS FCFHUM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HUM Yearly Current Assets VS Current LiabilitesHUM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

6

3. HUM Growth Analysis

3.1 Past

  • HUM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.81%.
  • The Earnings Per Share has been decreasing by -1.78% on average over the past years.
  • Looking at the last year, HUM shows a quite strong growth in Revenue. The Revenue has grown by 10.11% in the last year.
  • Measured over the past years, HUM shows a quite strong growth in Revenue. The Revenue has been growing by 10.94% on average per year.
EPS 1Y (TTM)5.81%
EPS 3Y-12.09%
EPS 5Y-1.78%
EPS Q2Q%-83.33%
Revenue 1Y (TTM)10.11%
Revenue growth 3Y11.77%
Revenue growth 5Y10.94%
Sales Q2Q%25.48%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.97% on average over the next years. This is quite good.
  • HUM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.51% yearly.
EPS Next Y-45.96%
EPS Next 2Y-5.2%
EPS Next 3Y14.43%
EPS Next 5Y14.97%
Revenue Next Year23.64%
Revenue Next 2Y14.79%
Revenue Next 3Y12.32%
Revenue Next 5Y10.51%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HUM Yearly Revenue VS EstimatesHUM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B 200B 250B
HUM Yearly EPS VS EstimatesHUM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40

5

4. HUM Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.66, the valuation of HUM can be described as very reasonable.
  • HUM's Price/Earnings ratio is rather cheap when compared to the industry. HUM is cheaper than 92.08% of the companies in the same industry.
  • HUM is valuated cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 17.87 indicates a rather expensive valuation of HUM.
  • Based on the Price/Forward Earnings ratio, HUM is valued a bit cheaper than 65.35% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, HUM is valued a bit cheaper.
Industry RankSector Rank
PE 9.66
Fwd PE 17.87
HUM Price Earnings VS Forward Price EarningsHUM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • HUM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HUM is cheaper than 86.14% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as HUM.
Industry RankSector Rank
P/FCF 53.2
EV/EBITDA 6.65
HUM Per share dataHUM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800 1K

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HUM's earnings are expected to grow with 14.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.2%
EPS Next 3Y14.43%

7

5. HUM Dividend Analysis

5.1 Amount

  • HUM has a Yearly Dividend Yield of 2.16%. Purely for dividend investing, there may be better candidates out there.
  • In the last 3 months the price of HUM has falen by -38.38%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.50, HUM pays a better dividend. On top of this HUM pays more dividend than 91.09% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, HUM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

  • The dividend of HUM is nicely growing with an annual growth rate of 7.57%!
  • HUM has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As HUM did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)7.57%
Div Incr Years0
Div Non Decr Years8
HUM Yearly Dividends per shareHUM Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • HUM pays out 36.20% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of HUM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP36.2%
EPS Next 2Y-5.2%
EPS Next 3Y14.43%
HUM Yearly Income VS Free CF VS DividendHUM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
HUM Dividend Payout.HUM Dividend Payout, showing the Payout Ratio.HUM Dividend Payout.PayoutRetained Earnings

HUM Fundamentals: All Metrics, Ratios and Statistics

HUMANA INC

NYSE:HUM (3/13/2026, 8:04:00 PM)

After market: 166 +0.57 (+0.34%)

165.43

+1.76 (+1.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-11
Earnings (Next)04-29
Inst Owners103.79%
Inst Owner Change3.21%
Ins Owners0.16%
Ins Owner Change8.5%
Market Cap19.95B
Revenue(TTM)129.66B
Net Income(TTM)1.19B
Analysts68.48
Price Target237.71 (43.69%)
Short Float %4.34%
Short Ratio2.62
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend3.57
Dividend Growth(5Y)7.57%
DP36.2%
Div Incr Years0
Div Non Decr Years8
Ex-Date03-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.95%
Min EPS beat(2)2.11%
Max EPS beat(2)13.8%
EPS beat(4)4
Avg EPS beat(4)8.66%
Min EPS beat(4)2.11%
Max EPS beat(4)13.88%
EPS beat(8)8
Avg EPS beat(8)11.46%
EPS beat(12)11
Avg EPS beat(12)-6.14%
EPS beat(16)15
Avg EPS beat(16)-1.63%
Revenue beat(2)2
Avg Revenue beat(2)7.03%
Min Revenue beat(2)0.98%
Max Revenue beat(2)13.08%
Revenue beat(4)3
Avg Revenue beat(4)3.32%
Min Revenue beat(4)-1.32%
Max Revenue beat(4)13.08%
Revenue beat(8)7
Avg Revenue beat(8)2.34%
Revenue beat(12)8
Avg Revenue beat(12)0.92%
Revenue beat(16)9
Avg Revenue beat(16)0.61%
PT rev (1m)-18.51%
PT rev (3m)-19.56%
EPS NQ rev (1m)-7.64%
EPS NQ rev (3m)-9.48%
EPS NY rev (1m)-23.13%
EPS NY rev (3m)-24.91%
Revenue NQ rev (1m)8.96%
Revenue NQ rev (3m)8.83%
Revenue NY rev (1m)9.96%
Revenue NY rev (3m)10.64%
Valuation
Industry RankSector Rank
PE 9.66
Fwd PE 17.87
P/S 0.15
P/FCF 53.2
P/OCF 21.66
P/B 1.13
P/tB 2.92
EV/EBITDA 6.65
EPS(TTM)17.13
EY10.35%
EPS(NY)9.26
Fwd EY5.6%
FCF(TTM)3.11
FCFY1.88%
OCF(TTM)7.64
OCFY4.62%
SpS1075.16
BVpS146.41
TBVpS56.74
PEG (NY)N/A
PEG (5Y)N/A
Graham Number237.55
Profitability
Industry RankSector Rank
ROA 2.43%
ROE 6.73%
ROCE 7.95%
ROIC 6.36%
ROICexc 7.05%
ROICexgc 16.75%
OM 2.63%
PM (TTM) 0.92%
GM N/A
FCFM 0.29%
ROA(3y)3.44%
ROA(5y)4.69%
ROE(3y)9.8%
ROE(5y)13.19%
ROIC(3y)7.34%
ROIC(5y)7.68%
ROICexc(3y)8.13%
ROICexc(5y)8.61%
ROICexgc(3y)17.98%
ROICexgc(5y)20.14%
ROCE(3y)9.27%
ROCE(5y)9.74%
ROICexgc growth 3Y-13.37%
ROICexgc growth 5Y-10.67%
ROICexc growth 3Y-13.16%
ROICexc growth 5Y-14.87%
OM growth 3Y-16.25%
OM growth 5Y-16.48%
PM growth 3Y-32.82%
PM growth 5Y-26.81%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover2.65
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 32.98
Debt/EBITDA 2.92
Cap/Depr 66.26%
Cap/Sales 0.42%
Interest Coverage 5.42
Cash Conversion 21.77%
Profit Quality 31.57%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.98%
ROIC/WACC0.8
Cap/Depr(3y)78.38%
Cap/Depr(5y)110.45%
Cap/Sales(3y)0.62%
Cap/Sales(5y)0.93%
Profit Quality(3y)116.42%
Profit Quality(5y)101.02%
High Growth Momentum
Growth
EPS 1Y (TTM)5.81%
EPS 3Y-12.09%
EPS 5Y-1.78%
EPS Q2Q%-83.33%
EPS Next Y-45.96%
EPS Next 2Y-5.2%
EPS Next 3Y14.43%
EPS Next 5Y14.97%
Revenue 1Y (TTM)10.11%
Revenue growth 3Y11.77%
Revenue growth 5Y10.94%
Sales Q2Q%25.48%
Revenue Next Year23.64%
Revenue Next 2Y14.79%
Revenue Next 3Y12.32%
Revenue Next 5Y10.51%
EBIT growth 1Y19.76%
EBIT growth 3Y-6.4%
EBIT growth 5Y-7.34%
EBIT Next Year-17.29%
EBIT Next 3Y16.99%
EBIT Next 5Y13.07%
FCF growth 1Y-84.32%
FCF growth 3Y-52.35%
FCF growth 5Y-39.63%
OCF growth 1Y-68.95%
OCF growth 3Y-41.44%
OCF growth 5Y-30.4%

HUMANA INC / HUM Fundamental Analysis FAQ

What is the fundamental rating for HUM stock?

ChartMill assigns a fundamental rating of 4 / 10 to HUM.


What is the valuation status for HUM stock?

ChartMill assigns a valuation rating of 5 / 10 to HUMANA INC (HUM). This can be considered as Fairly Valued.


What is the profitability of HUM stock?

HUMANA INC (HUM) has a profitability rating of 4 / 10.


Can you provide the financial health for HUM stock?

The financial health rating of HUMANA INC (HUM) is 1 / 10.


How sustainable is the dividend of HUMANA INC (HUM) stock?

The dividend rating of HUMANA INC (HUM) is 7 / 10 and the dividend payout ratio is 36.2%.